# Phase 32 — post-roadmap product, interface and release hardening

**Closed on 2026-11-05.** The Phase 32 closing release and production
verification complete the existing phased plan. The
[closure receipt](PRODUCTION_PHASE_32_CLOSURE_2026_11_05.md) records the deployed
application commit, Vercel alias, and live test outcomes.

## Closing-release preparation — 2026-11-04, READY for authorized execution

The [fresh final check](PHASE_32_CLOSING_RELEASE_CHECK_2026_11_04.md) passes:
**614 backend** (44 PostgreSQL), **347 frontend**, **17 security**, lint/types/build,
clean installation, clean npm/Python audits, reproducible Python locks,
**20 Edge journeys**, **28 standard HTTP**, **7 secondary HTTP** and **11 lifecycle
checks**. Approved target/configuration-presence checks and nine anonymous
production probes also pass. No product source or configuration changed.

The [deployment plan](PHASE_32_CLOSING_DEPLOYMENT_PLAN.md) records the candidate,
proposed commit, exact approved target, staged rollout and recovery reference.
Nothing was staged in Git, committed, pushed or deployed. Phase 32 and the
existing plan close after the authorized release passes exact-commit CI,
protected staging and stable-production verification; no new phase is created.

## FR-02 / FR-03 corrections — 2026-11-04, verified locally

Closed-chamber booking now rejects before allocation under the shared closure
lock; both race orders are covered in real PostgreSQL. Soft-deleted schedules
are excluded from unused chamber choices, while owned sessions keep accepted
bookings accessible. See [the correction report](FR_02_FR_03_CORRECTIONS_2026_11_04.md).

Fresh checks pass: **614 backend** (44 PostgreSQL), **347 frontend**, **17 security**,
lint/typecheck/build, **20 browser journeys**, **28 standard HTTP**, **7 secondary
HTTP** and **11 lifecycle checks**. Existing work, stack, dependency locks and migration head
0031 are preserved. Known review findings are resolved in local tested scope;
no publication was performed. Phase 32 remains open until its authorized closing
production release is verified. Earlier NOT READY checkpoints remain historical.

## Additional blocker review — 2026-11-04, NOT READY

FR-01 remains fixed, but new lifecycle checks confirm **FR-02/P2**: booking is
accepted after a chamber is closed, and the Doctor cannot reopen it to serve
that booking. **FR-03/P3** also leaves an unused facility selectable after its
schedule is soft-deleted. See [the recheck](DEPLOYMENT_BLOCKER_RECHECK_2026_11_04.md).
The new probe has 9/11 passing checks; dependency scans and approved-platform
identity/domain checks pass. Source is unchanged and no release was made.
Correct these two findings before the Phase 32 closing-release attempt.

## FR-01 secondary-facility correction — 2026-11-04, verified locally

The final assessment's secondary-facility care blocker is corrected. Verified
Doctors can select and service their published/owned-session facilities while
foreign access stays denied. Queue mutations serialize per Doctor across
facilities/dates, preventing competing current patients; legacy ambiguous state
fails closed. Accepted bookings survive practice-schedule retirement.

Fresh verification: **610 backend** (42 PostgreSQL), **346 frontend**, **17 security**,
lint/typecheck/build, **19 Edge journeys**, **28 standard HTTP** and **7/7 secondary
workflow reproduction checks**. The browser regression now reaches finalized
Citizen publication. See [the correction report](FR_01_SECONDARY_FACILITY_CORRECTION_2026_11_04.md).
No dependency/schema/stack change or publication was made. Phase 32 and the
existing phased plan remain open until the authorized closing release is live
and verified. Earlier NOT READY results below are historical pre-fix evidence.

## Final readiness assessment — 2026-11-04, NOT READY

The intended closing release has a new confirmed functional blocker, FR-01/P2.
Secondary-facility scheduling/booking succeeds, but the Doctor cannot view or
start that facility's chamber (409), while the primary control succeeds.
Existing secondary-booking coverage stops before the care workflow. See
[the final assessment](PHASE_32_FINAL_READINESS_2026_11_04.md) for independent
HTTP evidence, fresh white-/black-box results and the required safe correction.

Phase 32 and the current phased plan may close only after the corrected exact
candidate passes verification and an authorized production deployment is
recorded. No new phase, product change, commit, push or deployment was made by
this assessment. Prior passing correction reports retain their narrower scope.

Fresh gates pass: backend **602** (40 PostgreSQL), frontend **343**, security **17**,
lint/typecheck/build, clean isolated npm installation, clean npm/Python audits
and reproducible Python locks. Browser **19/19** and standard HTTP **28/28** pass;
the new secondary-care HTTP probe has **2 failures out of 7 checks**. Source
fingerprints are unchanged. The confirmed workflow failure governs readiness.

## Local QA defect corrections — 2026-11-04, not released

QA-01 is fixed: prescription AI now applies centralized publication rules before
medical extraction/provider/audit; Citizen drafts are denied while current
treating-Doctor draft access remains. Actual Finish Appointment makes the same
record available to its Citizen. QA-02's area retry waits for enabled Zila before
focus, with a deferred integration regression retaining focus assertions.

Fresh checks pass: **602 backend** (40 PostgreSQL), **343 frontend**, **17 security**,
lint/typecheck, optimized build, **19 Edge journeys**, **28 HTTP checks** and
**2 repeated area-retry probes**. See
[the correction report](QA_DEFECT_CORRECTIONS_2026_11_04.md) for exact evidence,
scope and limitations. The prior QA report remains historical pre-fix evidence.
No dependency/lock/schema change, commit, push or deployment was made;
publication remains held. This work continues Phase 32.

## Local white-box / black-box QA — 2026-11-03, issues found

Fresh testing of the unchanged local code passed backend 601, final frontend
343, security/adapter 17 and optimized-build browser 18 checks, with one earlier
intermittent frontend focus failure retained. Supplemental HTTP checks passed
27/28 and confirmed an owner-only draft-prescription AI explanation publication
bypass. See [the QA report](LOCAL_WHITE_BOX_BLACK_BOX_TEST_REPORT_2026_11_03.md)
for QA-01, QA-02, exact receipts and limits. No product fix or release was made;
publication remains held. This QA continuation stays within Phase 32.

## Minimal local dependency fix — 2026-11-03, not released

The owner requested a minimal fix that preserves the technology stack. The
existing Next/React/TypeScript/ESLint versions and lint configuration remain.
A private development adapter uses the patched minimatch 11.0.4 engine for the
legacy lint callers. Both audit gates now pass without using an exception;
17 security/adapter tests, 343 frontend tests, unchanged rule coverage,
TypeScript and the optimized build pass. See
[the fix report](MINIMAL_LINT_DEPENDENCY_FIX_2026_11_03.md).
No commit, push or deployment occurred; publication remains held.

## Release preflight — 2026-10-31, held

The owner authorized fresh checks followed by commit, push and deployment using
Mahim2077's existing GitHub/Vercel accounts. Project access is resolved. Fresh
verification passed 601 backend tests after a narrow pyasn1 0.6.5 security patch,
343 frontend tests, 10 security-gate tests, lint/typecheck, optimized builds and
18 Edge journeys. Python runtime/dev audits and reproducible hash locks pass.

The full npm development gate remains blocked by a new minimatch advisory with
no compatible published v3/v10 patch. No exception or incompatible override was
introduced. The owner explicitly chose to **keep the release held for an upstream
fix**. **No new commit, push or deployment occurred.** Follow
[the preflight report](PRE_RELEASE_PREFLIGHT_2026_10_31.md) for exact evidence,
the held release decision and safe resume conditions. This remains Phase 32.

## Local maintenance follow-up — 2026-10-24, not released

The production-survey corrections are implemented in the current working tree;
see [the correction report](SURVEY_BUGFIX_REPORT_2026_10_24.md). They preserve the
existing Phase 32 features while correcting publication rules, discovery and
booking, responsive/modal/form behavior, history navigation, historical PDF
metadata and misleading reminder copy. No production cleanup, migration, commit,
push or deployment is included. The released checkpoint below remains historical
and does not authorize releasing this new continuation.

## Released designation — 2026-10-22

The owner designated **all work after completion of the original Phase 31
roadmap as Phase 32** on **2026-10-22**, and authorized documenting, committing,
pushing and deploying the increment, now released as `6649931`. Follow the
[production receipt](PRODUCTION_PHASE_32_RELEASE_2026_10_22.md) for actual status.

## Boundary and numbering

Phases 0–31 keep their original scope. Phase 32 consolidates the subsequent
continuation, not a rewrite of older features or historical receipts. Earlier
commits, migration identifiers and dated test results remain intact.

**Migration numbers are not phase numbers.** `0031_ai_conversations` belongs to
the Phase 32 saved-chat continuation; do not rename it. The released Settings/
theme/security increment adds no migration. Expected production head remains 0031.

## Complete Phase 32 scope

| Area | Included continuation |
| --- | --- |
| Release reliability | Post-roadmap rollout/verification, protected staged smoke transport (`2bb55b8`), approved-target/stale-head checks, serialized migration → stage → smoke → promotion, release receipts and handoffs |
| Modern AI conversations | Approved sidebar/wide transcript/pinned composer/compact records control, mobile drawer, saved account-private history, reopen/follow-up, new chat, deletion, copy/timestamps and pagination |
| Chat persistence/privacy | Migration 0031, server-owned bounded context, retry idempotency, turn cap, owner/role enforcement and concurrent-delete protection; fresh one-request record consent and General-mode history isolation |
| Portal Settings | Citizen/professional/admin Account, Security and Display; citizen Privacy & sharing; verified-doctor Practice hours; existing identity/grant/session/schedule controls reused; legacy redirects and unsaved-edit protection |
| Shared UI/accessibility | Slimmer navigation, mobile focus trap/restoration and scroll lock, responsive Settings, keyboard-scrollable diagnostic tables; admin identity-detail async-params correction |
| Light / Dark / System | Browser-only allowlisted appearance/text/motion/sidebar preferences, pre-paint initialization, OS following, cross-tab sync, readable role/status/form/chat surfaces; light printing and unchanged generated PDFs |
| Dependency/CI security | Next.js/matching lint 16.4.2 and patched transitives; Python security patches; separate universal hash-locked runtime/dev requirements; lock freshness, strict advisory gates, immutable action pins and credential-free checkouts |
| QA and portability | Full backend/PostgreSQL/frontend/security/browser checks, responsive/theme/privacy regressions, integrity audits/remediation/rechecks, new-PC setup and updated agentic handoffs |

The saved-chat increment was **already released** as `21e94a5` on 2026-10-20.
Its Phase 32 designation is retrospective; this release does not recreate the
tables or duplicate that implementation. Earlier release-hardening receipts
remain dated evidence, even when their original title refers to Phase 31 rollout.

Explanation-only AI safety remains authoritative: no diagnosis, prescribing,
treatment changes, booking or clinical-record writes. No raw record-context
snapshot is stored in chat history. Display preferences contain no identity or
medical data. No automatic AI record-consent setting was introduced.

## Preserved foundations — not newly attributed to Phase 32

Configurable Groq AI foundation; specialist/nearest doctor discovery; private
admin-confirmed facility coordinates and Bangladesh district/upazila fallback;
merged Diagnostic tests; unified clinical notes/prescription; previous records
and on-demand PDF regeneration; scoped grants and clinical auditing; emergency
profiles and manual reminders. The scheduled reminder workflow remains removed.

## Latest local verification before release

The same application working tree passed a fresh recheck immediately before this
designation. These classification edits change documentation only; CI must still
verify the exact release commit.

- 567 backend/PostgreSQL, 298 frontend (61 files) and 10 security-gate tests.
- Lint, TypeScript and optimized build; Node 24.20.0 / Next.js 16.4.2.
- 14/14 optimized-build Edge journeys, including care, privacy, chat, Settings
  and responsive/Light/Dark/System checks.
- Both Python lock scans clean; all 103 installed packages clean against OSV;
  frontend production scan clean; byte-identical lock reproduction.
- Alembic head 0031/no drift; 57 validated foreign keys; 9 anonymous production probes.

One TestClient deprecation warning remains non-failing. The full npm scan retains
**one unpatched dev-only `braces@3.0.3` advisory**, inherited by five package
entries, with an exact-version exception through **2026-11-21**. Production has
no exception. Changed exposure/version, new findings, expired/invalid policy or
failed scan blocks the gate. Do not call this patched or silently extend it.

## Evidence index

- [Current handoff](../AGENTIC_IMPLEMENTATION_HANDOFF_CURRENT.md) and
  [Phase 32 production receipt](PRODUCTION_PHASE_32_RELEASE_2026_10_22.md).
- [Saved chat](AI_CONVERSATIONS_2026_10_19.md) and
  [earlier chat release](PRODUCTION_CHAT_RELEASE_2026_10_20.md).
- [Settings/theme audit](UI_SETTINGS_AUDIT_2026_10_20.md) and [design QA](../design-qa.md).
- [Original audit](PROJECT_INTEGRITY_AUDIT_2026_10_22.md),
  [remediation](DEPENDENCY_REMEDIATION_2026_10_22.md) and
  [fresh recheck](PROJECT_INTEGRITY_RECHECK_2026_10_22.md).
- [Dependency maintenance](DEPENDENCY_SECURITY.md),
  [new-PC setup](NEW_PC_DEVELOPMENT_SETUP.md) and [progress](implementation-progress.md).

## Authority and completion

The owner's 2026-10-22 instruction supersedes earlier local release holds for
this Phase 32 release only. Use **Mahim2077/HealthLink**, `main`, and the approved
Mahim2077 Vercel connection, **mahim2077s-projects / healthlink-sd**. No alternate
account/project, secret rotation, permission downgrade or real clinical-data
mutation is authorized by this release.

Production completion is recorded in the linked receipt: application `6649931`,
successful Actions run `39808112467`, READY production deployment and independently
verified stable origin. No medical safety, provider privacy, backup or monitoring
certification is implied by the tests; the receipt records actual acceptance limits.
